We estimate that the President & CEO of DEXCOM INC ($DXCM), Jacob Leach, received a compensation of $7,985,960 in 2025. This is an increase of 25.84% from an estimated $5,922,271 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on April 15, 2026. Note that parsing errors may occur.
You can track $DXCM on Quiver Quantitative's $DXCM stock dashboard.
$DXCM Stock Insider Trading Activity
$DXCM Stock insiders have traded $DXCM stock on the open market 7 times in the past 6 months. Of those trades, 2 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $DXCM stock by insiders over the last 6 months:
- JACOB STEVEN LEACH (President & COO) has made 2 purchases buying 18,200 shares for an estimated $1,001,701 and 0 sales.
- RICHARD ALEXANDER COLLINS has made 0 purchases and 2 sales selling 6,854 shares for an estimated $389,410.
- BRIDGETTE P HELLER has made 0 purchases and 2 sales selling 2,024 shares for an estimated $127,592.
- MICHAEL JON BROWN (EVP, Chief Legal Officer) sold 1,700 shares for an estimated $110,244
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$DXCM Stock Congressional Stock Trading
Members of Congress have traded $DXCM stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $DXCM stock by members of Congress over the last 6 months:
- SENATOR JOHN BOOZMAN purchased up to $15,000 on 01/26.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$DXCM Stock Hedge Fund Activity
We have seen 478 institutional investors add shares of $DXCM Stock stock to their portfolio, and 431 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 21,931,067 shares (-73.3%) from their portfolio in Q4 2025, for an estimated $1,455,564,916
- ALLIANCEBERNSTEIN L.P. added 8,204,553 shares (+1955.4%) to their portfolio in Q4 2025, for an estimated $544,536,182
- CITADEL ADVISORS LLC removed 6,691,590 shares (-98.7%) from their portfolio in Q4 2025, for an estimated $444,120,828
- SANDS CAPITAL MANAGEMENT, LLC removed 4,934,189 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $327,482,123
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 4,815,048 shares (-85.9%) from their portfolio in Q4 2025, for an estimated $319,574,735
- JENNISON ASSOCIATES LLC removed 4,300,430 shares (-42.6%) from their portfolio in Q4 2025, for an estimated $285,419,539
- WELLINGTON MANAGEMENT GROUP LLP added 2,994,303 shares (+3777.3%) to their portfolio in Q4 2025, for an estimated $198,731,890
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$DXCM Stock Analyst Ratings
Wall Street analysts have issued reports on $DXCM in the last several months. We have seen 11 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 02/13/2026
- Barclays issued a "Underweight" rating on 01/12/2026
- Mizuho issued a "Outperform" rating on 12/17/2025
- Argus Research issued a "Buy" rating on 11/07/2025
- UBS issued a "Buy" rating on 11/03/2025
- Piper Sandler issued a "Overweight" rating on 10/31/2025
- RBC Capital issued a "Outperform" rating on 10/31/2025
To track analyst ratings and price targets for $DXCM Stock, check out Quiver Quantitative's $DXCM forecast page.
$DXCM Stock Price Targets
Multiple analysts have issued price targets for $DXCM recently. We have seen 17 analysts offer price targets for $DXCM in the last 6 months, with a median target of $85.0.
Here are some recent targets:
- Joanne Wuensch from Citigroup set a target price of $84.0 on 03/11/2026
- Marie Thibault from BTIG set a target price of $85.0 on 03/09/2026
- Richard Newitter from Truist Securities set a target price of $80.0 on 02/17/2026
- Anthony Petrone from Mizuho set a target price of $90.0 on 02/13/2026
- Matt Miksic from Barclays set a target price of $72.0 on 02/13/2026
- Larry Biegelsen from Wells Fargo set a target price of $85.0 on 02/13/2026
- William Plovanic from Canaccord Genuity set a target price of $95.0 on 02/13/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
